Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay

被引:20
|
作者
Barnes, Edward L. [1 ]
Kochar, Bharati [1 ]
Long, Millie D. [1 ,2 ]
Martin, Christopher F. [1 ,2 ]
Kappelman, Michael D. [2 ,3 ]
机构
[1] Univ North Carolina Chapel Hill, Div Gastroenterol & Hepatol, 130 Mason Farm Rd,Bioinformat Bldg,CB 7080, Chapel Hill, NC 27599 USA
[2] Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Div Pediat Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
race; length of stay; pediatric inflammatory bowel disease; SERIOUS BACTERIAL-INFECTIONS; FACTOR-ALPHA ANTAGONISTS; NON-HISPANIC WHITES; UNITED-STATES; ULCERATIVE-COLITIS; CROHNS-DISEASE; AFRICAN-AMERICANS; RETROSPECTIVE COHORT; RACIAL DISPARITIES; COLECTOMY RATES;
D O I
10.1097/MIB.0000000000001267
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic and other biological factors may lead to differences in disease behavior among children with inflammatory bowel disease of different races, which may be further modified by disparities in care delivery. Using the Kids' Inpatient Database, we aimed to evaluate differences in the management of pediatric patients with inflammatory bowel disease by race, focusing on length of stay (LOS). Methods: We performed a cross-sectional analysis using 2000 to 2012 data from the Kids' Inpatient Database, a nationally representative database. We identified pediatric patients (<= 18 years of age) with discharge diagnoses of Crohn's disease (CD) or ulcerative colitis (UC). We used multivariable logistic regression to evaluate the relationship between race and LOS, controlling for age, payer status need for surgery, and year of admission. Results: We identified 27,295 hospitalizations for children with inflammatory bowel disease (62% CD and 38% UC), Compared with white patients with CD, black (adjusted odds ratio 1.37; 95% confidence interval, 1.22-1.53; P < 0.001) and Hispanic patients (adjusted odds ratio: 1.37; 95% confidence interval: 1.19-1.59; P < 0.001) with CD demonstrated increased odds of a LOS greater than the 75th percentile. When compared with white patients with UC, Hispanic patients also demonstrated increased odds of a LOS greater than the 75th percentile (adjusted odds ratio: 1.20; 95% confidence interval, 1.02-1.42, P = 0.015). Conclusions: After controlling for age, year of admission, and clinical phenotypes, black and Hispanic patients with CD and Hispanic patients with UC had longer LOS than white patients. These may be due to differences in provider/hospital characteristics, socioeconomic differences, and/or differences in genetics and other biological factors.
引用
收藏
页码:2189 / 2196
页数:8
相关论文
共 50 条
  • [41] The Treatment of Pediatric Inflammatory Bowel Disease with Biologic Therapies
    Conrad M.A.
    Kelsen J.R.
    Current Gastroenterology Reports, 2020, 22 (8)
  • [42] Role of ileal diversion in pediatric inflammatory bowel disease
    Simard, Amanda A.
    Kotamraju, Swetha
    DeFazio, Jennifer R.
    Picoraro, Joseph A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (04) : 800 - 806
  • [43] Dermatological impacts associated with pediatric inflammatory bowel disease
    Martin de Carpi, J.
    Baselga, E.
    BOLETIN DE PEDIATRIA, 2014, 54 (229): : 140 - 147
  • [44] Development of Extraintestinal Manifestations in Pediatric Patients with Inflammatory Bowel Disease
    Jose, Folashade Adebisi
    Garnett, Elizabeth A.
    Vittinghoff, Eric
    Ferry, George D.
    Winter, Harland S.
    Baldossano, Robert N.
    Kirschner, Barbara S.
    Cohen, Stanley A.
    Gold, Benjamin D.
    Abramson, Oren
    Heyman, Melvin B.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 63 - 68
  • [45] Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
    Halling, Morten L.
    Kjeldsen, Jens
    Knudsen, Torben
    Nielsen, Jan
    Hansen, Lars Koch
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (33) : 6137 - 6146
  • [46] Pediatric inflammatory bowel disease, a review
    Grez, Catalina
    Cristobal Ossacd, Juan
    REVISTA MEDICA CLINICA LAS CONDES, 2019, 30 (05): : 372 - 382
  • [47] Mechanisms of Pediatric Inflammatory Bowel Disease
    Peloquin, Joanna M.
    Goel, Gautam
    Villablanca, Eduardo J.
    Xavier, Ramnik J.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 : 31 - 64
  • [48] Adalimumab in Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [49] Update in Pediatric Inflammatory Bowel Disease
    Rabizadeh, Shervin
    Dubinsky, Marla
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2013, 39 (04) : 789 - +
  • [50] Epidemiology of Pediatric Inflammatory Bowel Disease
    Khan, Rabia
    Kuenzig, Ellen
    Benchimol, Eric I.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2023, 52 (03) : 483 - 496